Keith R Leonard's Net Worth
$3.41 Million
Who is Keith R Leonard?
Keith R Leonard has an estimated net worth of $3.41 Million. This is based on reported shares across multiple companies, which include INTUITIVE SURGICAL INC, KYTHERA BIOPHARMACEUTICALS INC, Anacor Pharmaceuticals, Inc., ARYx Therapeutics, Inc., Arcutis Biotherapeutics, Inc., Unity Biotechnology, Inc., Sienna Biopharmaceuticals, Inc., and AFFYMAX INC.
SEC CIK
Keith R Leonard's CIK is 0001416180
Past Insider Trading and Trends
2019 was Keith R Leonard's most active year for acquiring shares with 9 total transactions. Keith R Leonard's most active month to acquire stocks was the month of March. 2015 was Keith R Leonard's most active year for disposing of shares, totalling 13 transactions. Keith R Leonard's most active month to dispose stocks was the month of March. 2021 saw Keith R Leonard paying a total of $460,859.16 for 59,900 shares, this is the most they've acquired in one year. In 2021 Keith R Leonard cashed out on 2,247 shares for a total of $996,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTUITIVE SURGICAL INC (ISRG) Snapshot price: $467.687
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
| +54.87% | 569 |
—
|
—
| 1.61K |
Apr 25
| |||
Form 4
| -71.07% | -2.55K |
—
|
—
| 1.04K |
Feb 15
| |||
Form 4
| +15.54% | 482 |
—
|
—
| 3.58K |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
| +21.79% | 555 |
—
|
—
| 3.1K |
Apr 22
| |||
Form 4
|
—
|
0
|
$731.36 | -$535,140.84 | 849 |
Scheduled
|
Aug 3
| ||
Form 4
| +42.93% | 255 |
—
|
—
| 849 |
Apr 22
| |||
Form 4
| +78.92% | 262 |
—
|
—
| 594 |
Apr 23
| |||
Form 4
|
—
|
0
|
$435.74 | -$507,558.30 | 332 |
Scheduled
|
Feb 13
| ||
Form 4
| -60.71% | -513.00 |
—
|
—
| 332 |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
| +64.72% | 332 |
—
|
—
| 845 |
Apr 19
| |||
Form 4
|
∞
| 513 |
—
|
—
| 513 |
Apr 19
| |||
Form 4
| -100.00% | -427.00 |
$807.45 | -$591,436.43 |
0
|
Scheduled
|
Aug 31
| ||
Form 4
| +327.00% | 327 |
—
|
—
| 427 |
Apr 20
| |||
Form 4
|
∞
| 100 |
—
|
—
| 100 |
Jan 29 - Jan 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KYTHERA BIOPHARMACEUTICALS INC No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -838.85K |
—
|
—
|
0
|
Jul 21 - Oct 1
| |||
Form 4
| -1.99% | -16.83K |
$50.16 | -$844,182.45 | 829.74K |
Scheduled
|
Jun 1
| ||
Form 4
| -0.41% | -3.50K |
$50.04 | -$175,150.50 | 846.57K |
Scheduled
|
May 20
| ||
Form 4
| -1.51% | -13.00K |
$44.93 | -$584,049.75 | 850.07K |
Scheduled
|
May 1
| ||
Form 4
|
∞
| 9.11K |
$45.29 | -$251,691.97 | 9.11K |
Apr 29 - Apr 30
| |||
Form 4
| -0.16% | -2.71K |
$50.54 | -$136,869.07 | 1.72M |
Scheduled
|
Apr 15
| ||
Form 4
| -1.55% | -13.55K |
$48.14 | -$652,183.18 | 860.69K |
Scheduled
|
Apr 1
| ||
Form 4
| -0.60% | -5.31K |
$50.16 | -$266,436.15 | 874.24K |
Scheduled
|
Mar 16
| ||
Form 4
| -1.19% | -10.63K |
$40.94 | -$434,962.20 | 879.55K |
Scheduled
|
Mar 2
| ||
Form 4
| -0.47% | -4.17K |
$40.46 | -$168,505.07 | 890.17K |
Scheduled
|
Feb 17
| ||
Form 4
| -3.75% | -34.89K |
$36.70 | -$229,358.64 | 894.34K |
Scheduled
|
Jan 15 - Feb 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
∞
| 28.64K |
$6.06 | $173,576.58 | 28.64K |
Jan 6
| |||
Form 4
| -0.70% | -6.12K |
$35.37 | -$216,490.80 | 871.95K |
Scheduled
|
Jan 2
| ||
Form 4
| -0.68% | -5.99K |
$37.60 | -$225,349.62 | 878.07K |
Scheduled
|
Dec 1
| ||
Form 4
| -0.66% | -5.87K |
$34.95 | -$204,954.18 | 884.06K |
Scheduled
|
Nov 3
| ||
Form 4
| -0.21% | -1.91K |
$35.13 | -$67,209.81 | 889.92K |
Scheduled
|
Oct 23
| ||
Form 4
| -0.43% | -3.83K |
$32.55 | -$124,540.89 | 891.84K |
Scheduled
|
Oct 1
| ||
Form 4
| -0.62% | -5.61K |
$37.40 | -$209,839.81 | 895.66K |
Scheduled
|
Sep 2
| ||
Form 4
| -0.20% | -1.83K |
$35.10 | -$64,161.89 | 901.27K |
Scheduled
|
Aug 4
| ||
Form 4
| -0.40% | -3.66K |
$32.80 | -$119,918.74 | 903.1K |
Scheduled
|
Aug 1
| ||
Form 4
| -0.97% | -8.93K |
$39.47 | -$352,300.83 | 906.76K |
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
| -0.19% | -1.74K |
$36.58 | -$63,750.57 | 915.68K |
Scheduled
|
Jun 16
| ||
Form 4
| -0.38% | -3.49K |
$32.54 | -$113,434.81 | 917.43K |
Scheduled
|
Jun 2
| ||
Form 4
| -0.18% | -1.70K |
$35.02 | -$59,537.06 | 920.91K |
Scheduled
|
May 27
| ||
Form 4
| -0.18% | -3.40K |
$32.54 | -$110,708.04 | 1.84M |
Scheduled
|
May 1
| ||
Form 4
| -1.42% | -13.26K |
$39.08 | -$518,201.94 | 919.72K |
Scheduled
|
Apr 1
| ||
Form 4
| -1.37% | -13.00K |
$49.20 | -$639,651.77 | 932.98K |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
—
|
—
| 945.98K |
Jan 22 - Jan 27
| |||
Form 4
| -1.39% | -12.74K |
$45.35 | -$577,755.40 | 903.53K |
Scheduled
|
Feb 3
| ||
Form 4
| +1,075.79% | 47.99K |
$5.32 | $255,312.12 | 52.45K |
Jan 6
| |||
Form 4
| -1.34% | -12.48K |
$37.38 | -$466,452.00 | 916.27K |
Scheduled
|
Jan 2
| ||
Form 4
| +0.41% | 3.85K |
$21.96 | -$0.33 | 933.21K |
Dec 27
| |||
Form 4
| -1.30% | -12.22K |
$38.95 | -$476,009.43 | 929.36K |
Scheduled
|
Dec 2
| ||
Form 4
| -1.25% | -11.96K |
$44.22 | -$528,886.21 | 941.58K |
Scheduled
|
Nov 1
| ||
Form 4
| -1.21% | -11.70K |
$46.05 | -$538,818.98 | 953.54K |
Scheduled
|
Oct 1
| ||
Form 4
| -0.30% | -2.86K |
$33.62 | -$96,143.48 | 965.24K |
Scheduled
|
Sep 16
| ||
Form 4
| -0.88% | -8.58K |
$26.12 | -$224,134.48 | 968.1K |
Scheduled
|
Sep 3
| ||
Form 4
| -0.85% | -8.38K |
$26.73 | -$224,135.24 | 976.68K |
Scheduled
|
Aug 1
| ||
Form 4
| -0.14% | -1.36K |
$28.90 | -$39,454.37 | 985.07K |
Scheduled
|
Jul 15
| ||
Form 4
| -0.82% | -8.19K |
$27.10 | -$221,912.14 | 986.43K |
Scheduled
|
Jul 1
| ||
Form 4
| -0.13% | -1.33K |
$25.69 | -$34,212.60 | 994.62K |
Scheduled
|
Jun 17
| ||
Form 4
| -0.66% | -6.66K |
$21.25 | -$141,596.08 | 1M |
Scheduled
|
Jun 3
| ||
Form 4
| -0.15% | -1.51K |
—
|
—
| 1M |
May 21
| |||
Form 4
| -0.69% | -6.88K |
$23.42 | -$161,151.30 | 1M |
Scheduled
|
May 1 - May 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| -0.75% | -7.56K |
—
|
—
| 1M |
Dec 21
| |||
Form 4
| +155.44% | 614.53K |
—
|
—
| 1.01M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Anacor Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -794.00 |
$99.25 | -$78,804.50 |
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
$56.96 | -$769,320.00 | 794 |
May 23
| |||
Form 4
|
∞
| 794 |
—
|
—
| 794 |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARYx Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +116.71% | 10.14K |
—
|
—
| 18.83K |
Jun 14
| |||
Form 4
| +101.46% | 4.38K |
—
|
—
| 8.69K |
May 31
| |||
Form 4
|
∞
| 4.31K |
—
|
—
| 4.31K |
Jun 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |